Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, analytical instrument specialist Thermo Fisher Scientific
With that in mind, let's take a closer look at Thermo Fisher's business and see what CAPS investors are saying about the stock right now.
Thermo Fisher facts
|Headquarters (Founded)||Waltham, Mass. (1956)|
|Market Cap||$19.6 billion|
|Industry||Life sciences tools and services|
|Trailing-12-Month Revenue||$11.5 billion|
|Management||CEO Marc Casper (since 2009)
CFO Peter Wilver (since 2004)
|Return on Equity (Average, Past 3 Years)||6.3%|
|Cash/Debt||$898.3 million / $7.1 billion|
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 96% of the 567 members who have rated Thermo Fisher believe the stock will outperform the S&P 500 going forward.
Thermo Fisher … has a history of beating their consensus expectations. ... [E]ven analyst bearish cases forecast top line revenue growth and EPS estimates holding the line, so to speak. I think that the present valuation is pricing in the analyst worst case scenario. There is upside here and I think that this one got beat up by tax loss selling last year and the swing up that you've seen so far this year is simply the January effect. Is there more to this beyond just an effect? I think so. Target: $52-$57.
What do you think about Thermo Fisher, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future.
Despite a perfect five-star rating, Thermo Fisher may not be your top choice. We've found another stock we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2012." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.
Want to see how well (or not so well) the stocks in this series are performing? Follow the new TrackPoisedTo CAPS account.
Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Motley Fool newsletter services have recommended buying shares of Thermo Fisher and Becton Dickinson. Try any of our Foolish newsletter services free for 30 days.
More from The Motley Fool
5 Top Nanotechnology Stocks to Buy
Investors intrigued by the promise of nanotech should give these nanotechnology stocks a closer look.
Why Patheon N.V. Is Soaring Today
Shares skyrocketed after the company accepted a takeover bid from Thermo Fisher Scientific.
The Unsung Heroes of CAR-T
Investors are well aware of the big names in CAR-T therapies, but these companies are working behind the scenes to make marketable treatments possible.